Research Article
A Retrospective Study of Cytology, High-Risk HPV, and Colposcopy Results of Vaginal Intraepithelial Neoplasia Patients
Table 5
Cytology/hrHPV sensitivity in VaIN patients after hysterectomy and with no hysterectomy.
| | VaIN | No hysterectomy | After hysterectomy | value |
| | Cytology sensitivity | | | | | VaIN | 59.5% (194/326) | 69.6% (55/79) | 0.098 | | VaIN1 | 59.6% (174/292) | 64.2% (34/53) | 0.532 | | VaIN2/3 | 58.8% (20/34) | 80.8% (21/26) | 0.070 | | hrHPV sensitivity | | | | | VaIN | 86.5% (239/276) | 90.4% (66/73) | 0.382 | | VaIN1 | 85.7% (210/245) | 89.4% (42/47) | 0.505 | | VaIN2/3 | 93.5% (29/31) | 92.3% (24/26) | 0.855 | | Cotesting sensitivity | | | | | VaIN | 91.9% (239/260) | 98.5% (65/66) | 0.058 | | VaIN1 | 91.9% (216/235) | 97.7% (43/44) | 0.170 | | VaIN2/3 | 92.0% (23/25) | 100.0% (22/22) | 0.175 |
|
|
VaIN: vaginal intraepithelial neoplasia; hrHPV: high-risk human papillomavirus.
|
